Helen S. Atkins

Salisbury, ENG SP40JQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Inhaled Ciprofloxacin as an Alternative Treatment for Infection with Coxiella burnetii.

Inhaled Ciprofloxacin as an Alternative Treatment for Infection with Coxiella burnetii.

Journal: Antibiotics (Basel, Switzerland)

Published: January 13, 2026

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.

Journal: EClinicalMedicine

Published: June 21, 2024

An Investigation into the Potential of Targeting Escherichia coli rne mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy.

An Investigation into the Potential of Targeting Escherichia coli rne mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy.

Journal: Molecules (Basel, Switzerland)

Published: March 26, 2021

Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species.

Drug screening to identify compounds to act as co-therapies for the treatment of Burkholderia species.

Journal: PloS one

Published: September 10, 2020

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.

Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: July 07, 2020

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: May 15, 2020

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: May 15, 2020

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: April 30, 2020

Identification and analysis of novel small molecule inhibitors of RNase E: Implications for antibacterial targeting and regulation of RNase E.

Identification and analysis of novel small molecule inhibitors of RNase E: Implications for antibacterial targeting and regulation of RNase E.

Journal: Biochemistry and biophysics reports

Published: February 05, 2020

Genome-wide assessment of antimicrobial tolerance in Yersinia pseudotuberculosis under ciprofloxacin stress.

Genome-wide assessment of antimicrobial tolerance in Yersinia pseudotuberculosis under ciprofloxacin stress.

Journal: Microbial genomics

Published: October 04, 2019

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.

Journal: Frontiers in microbiology

Published: February 14, 2019

Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.

Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.

Journal: International journal of antimicrobial agents

Published: January 08, 2019

Showing 1-12 of 37

Last Updated: 09/26/2026